Nachrichten zur Illumina Inc. Aktie

Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed

Illumina said on Tuesday Chief Financial Officer Joydeep Goswami would leave the gene sequencing company and would be succeeded by…

Illumina CFO Goswami to depart, Summit Therapeutics Dhingra named successor By Reuters

Illumina CFO Goswami to depart, Summit Therapeutics Dhingra named successor…

Illumina: Downgrade

New York (www.aktiencheck.de) - Rating-Update: Die Analysten von OTR Global stufen die Aktie von Illumina Inc. (ISIN: US4523271090, WKN: 927079, Ticker-Symbol:…

EU court should back Illuminas appeal against EU review of Grail deal, court adviser says By Reuters

EU court should back Illuminas appeal against EU review of Grail deal, court adviser says…

Illumina shares fall as Ichan reportedly abandons second proxy contest By Investing.com

Illumina shares fall as Ichan reportedly abandons second proxy contest…

Exclusive-Icahn drops Illumina board challenge threat, sources say

Activist investor Carl Icahn has dropped a threat to mount a new challenge to Illuminas board, sparing the U.S. gene…

Exclusive-Icahn drops Illumina board challenge threat, sources say By Reuters

Exclusive-Icahn drops Illumina board challenge threat, sources say…

Illuminas Turnaround Play: Betting On NovaSeq X Amidst Rising Competitive Tides

…

ILLUMINA ALERT: Bragar Eagel & Squire, P.C. is Investigating Illumina, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

NEW YORK, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

Kursgewinne für den Anteilsschein von Illumina (126,1800 €)

Am US-amerikanischen Aktienmarkt notiert die Illumina-Aktie zur Stunde fester. Zuletzt zahlten Investoren für die Aktie 136,87 US-Dollar. Der Anteilsschein von…

4 Overvalued Stocks Ripe for a Short as Market Scrambles for Direction After ATHs

Stocks Analysis by Investing.com (Ismael De La Cruz) covering: S&P 500, Illumina Inc, DexCom Inc, Insulet Corporation. Read Investing.com (Ismael…

Illumina (ILMN) Rides on NGS Portfolio Expansion Amid Macro Woe

In reproductive health, Illumina (ILMN) primarily focuses on driving noninvasive prenatal testing (NIPT) adoption globally.…

Illumina, Inc. (ILMN) Q4 2023 Earnings Call Transcript

…

Illumina forecasts flat 2024 sales as sluggish demand drags on By Reuters

Illumina forecasts flat 2024 sales as sluggish demand drags on…

Global Nucleic Acid Sample Preparation Kit Market Size To Worth USD 11,200.5 Million By 2033 | CAGR of 10.27%

The Global Nucleic Acid Sample Preparation Kit Market Size was valued at USD 4,213.0 Million in 2023 and the Worldwide…

Analyst Report: Illumina Inc

…

Prenatal DNA Sequencing: Global Market Analysis Through 2018-2033 by Type, Application, End User and Region

Dublin, Jan. 19, 2024 (GLOBE NEWSWIRE) -- The "Prenatal DNA Sequencing Global Market Report 2024" report has been…

Concentric by Ginkgo and Illumina join hands for pathogen monitoring programs

…

Illumina (ILMN) Shares Down 1.2% Post Preliminary Q4 Results

Illuminas (ILMN) fourth-quarter 2023 results are likely to reflect the impacts of the adoption of its new generation of distributed…

Illumina, Inc. (ILMN) J.P. Morgan 42nd Annual Healthcare Conference (Transcript)

…

Illumina unveils preliminary fourth-quarter revenue that tops estimates By Investing.com

Illumina unveils preliminary fourth-quarter revenue that tops estimates…

Illumina: Abstufung

New York (www.aktiencheck.de) - Rating-Update: Die Analysten von TD Cowen stufen die Aktie von Illumina Inc. (ISIN: US4523271090, WKN: 927079, Ticker-Symbol:…

ILLUMINA DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Illumina, Inc. and Encourages Investors to Contact the Firm

NEW YORK, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights…

ILMN FINAL DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, Encourages Illumina, Inc. Investors to Secure Counsel Before Important January 9 Deadline in Securities Class Action – ILMN

NEW YORK, Jan. 05, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Illumina, Inc. (ILMN)

LOS ANGELES, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of…

ILLUMINA SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Illumina To Contact Him Directly To Discuss Their Options

If you suffered losses exceeding $100,000 investing in Illumina securities between September 21, 2020 and November 9, 2023 and would…

Pfizer and Illumina downgraded but Merck can deliver, declares TD Cowen By Investing.com

Pfizer and Illumina downgraded but Merck can deliver, declares TD Cowen…

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Illumina, Inc. (ILMN) Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Illumina, Inc. ("Illumina"…

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Illumina, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 9, 2024 – (NASDAQ: ILMN)

NEW YORK, Jan. 03, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Acelyrin, Illumina, and Roblox and Encourages Investors to Contact the Firm

NEW YORK, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Illumina, Inc. Investors with Losses to Secure Counsel Before Important January 9 Deadline in Securities Class Action – ILMN

NEW YORK, Jan. 01, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…

ILMN Final Deadline: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Lead Plaintiff Deadline in Securities Fraud Class Action Lawsuit Filed against Illumina, Inc. (ILMN)

RADNOR, Pa., Dec. 31, 2023 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Acelyrin, Illumina, and Roblox and Encourages Investors to Contact the Firm

NEW YORK, Dec. 28, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Illumina, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 9, 2024 – (NASDAQ: ILMN)

NEW YORK, Dec. 28, 2023 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders…

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Illumina, Inc. Investors to Secure Counsel Before Important January 9 Deadline in Securities Class Action – ILMN

NEW YORK, Dec. 28, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…

Heres Why You Should Retain Illumina (ILMN) Stock for Now

Investors are optimistic about Illuminas (ILMN) strength in the genomics market and strong solvency position.…

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Illumina, Inc. (ILMN)

LOS ANGELES, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of…

Class Action Lawsuit Filed Against Illumina, Inc. (ILMN) on Behalf of Investors – Nationally Ranked Investors’ Rights Firm Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm

ATLANTA, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC informs investors that a shareholder class action…

ILLUMINA SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Illumina To Contact Him Directly To Discuss Their Options

If you suffered losses exceeding $100,000 investing in Illumina securities between September 21, 2020 and November 9, 2023 and would…

ILLUMINA ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Illumina, Inc. and Encourages Investors to Contact the Firm

NEW YORK, Dec. 24, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights…

ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Illumina, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – ILMN

NEW YORK, Dec. 24, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Illumina, Inc. (ILMN)

NEW YORK, Dec. 22, 2023 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action…

Final Deadline Approaching for Illumina, Inc. Investors: Kessler Topaz Meltzer & Check, LLP Reminds Illumina, Inc. (ILMN) Investors of January 9, 2024 Lead Plaintiff Deadline

RADNOR, Pa., Dec. 22, 2023 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP…

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Illumina, Inc. - ILMN

NEW YORK, Dec. 22, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Illumina, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 9, 2024 – (NASDAQ: ILMN)

NEW YORK, Dec. 20, 2023 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders…

Illumina: Pläne zur Veräußerung von Grail - Aktienanalyse

Toronto (www.aktiencheck.de) - Illumina-Aktienanalyse von RBC Capital Markets: Conor McNamara, Analyst von RBC Capital Markets, senkt in einer aktuellen Aktienanalyse das…

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Illumina, Inc. (ILMN)

LOS ANGELES, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the…

ROSEN, LEADING INVESTOR COUNSEL, Encourages Illumina, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – ILMN

NEW YORK, Dec. 18, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…

Icahn Escalates Boardroom Battle at Illumina with Second Proxy Challeng By Quiver Quantitative

Icahn Escalates Boardroom Battle at Illumina with Second Proxy Challeng…

Icahn Escalates Boardroom Battle at Illumina with Second Proxy Challenge By Quiver Quantitative

Icahn Escalates Boardroom Battle at Illumina with Second Proxy Challenge…